Safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of HRS-1893, a cardiac myosin inhibitor, in healthy subjects. (PubMed, Br J Clin Pharmacol) - May 21, 2026 - P1 | "HRS-1893 demonstrated favourable safety and PK profiles, with potential therapeutic efficacy among healthy subjects."
First-in-human • Journal • PK/PD data
|
|
Feng He; Jun Feng; Kexu Yang; Meng Fu; Min Hu; Shan Jing; Ting Zhang; Wenfang Liu; Xi Li; Xiaoyi Sun; Yang Lin
|